Geftiget 250mg Tablet

Introduction to Geftiget 250mg Tablet

The Geftiget 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain genetic mutations called EGFR mutations. This tablet is often prescribed to patients who have not undergone chemotherapy before.

Composition of Geftiget 250mg Tablet

The active ingredient in Geftiget 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it targets and blocks specific proteins that promote the growth of cancer cells.

Uses of Geftiget 250mg Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftiget 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftiget 250mg Tablet

Geftiget 250mg Tablet should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftiget 250mg Tablet

• Take one tablet orally once daily.
• Consume at the same time each day for best results.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Geftiget 250mg Tablet

The Geftiget 250mg Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and to take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.